Pathogenesis of Epstein-Barr Virus (EBV)-carrying lymphomas

Acta Microbiologica et Immunologica Hungarica

Volumn 53, Issue 4, 2006, Pages 441-457

  Klein, Eva ^a   Kis, L L ^a   Takahara, M ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Epstein Barr virus; Lymphomas

Indexed keywords

HUMAN HERPESVIRUS 4;

ANIMAL; B LYMPHOCYTE; BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; HUMAN; IMMUNOLOGY; LYMPHOBLASTOMA; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE; VIROLOGY;

ANIMALS; B-LYMPHOCYTES; BURKITT LYMPHOMA; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, LYMPHOBLASTIC; T-LYMPHOCYTES;

EID: 33847785240     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.53.2006.4.3     Document Type: Article

References (61)

1. Rickinson, A. B., Kieff, E.: Epstein-Barr virus. In: Knipe, D.M., Howley, P. M., editors, Fields Virology, Lippincott Williams and Wilkins, Philadelphia (2001), pp. 2575-2628.
2. Hammerschmidt, W., Sugden, B.: Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393 (1989).
3. Kaye, K. M., Izumi, K. M., Kieff, E.: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90, 9150 (1993)
4. Thorley-Lawson, D. A.: Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1, 75 (2001).
5. Schaefer, B. C., Strominger, J. L., Speck, S. H.: Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci U S A 92, 10565 (1995).
6. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., Masucci, M. G.: Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375, 685 (1995).
7. Hochberg, D., Middeldorp, J. M., Catalina, M., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A.: Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101, 239 (2004).
8. Chen, F., Zou, J. Z., di Renzo, L., Winberg, G., Hu, L. F., Klein, E., Klein, G., Ernberg, I.: A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69, 3752 (1995).
9. Fahraeus, R., Fu, H. L., Ernberg, I., Finke, J., Rowe, M., Klein, G., Falk, K., Nilsson, E., Yadav, M., Busson, P., Tursz, T., Kallin, B.: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42, 329 (1988).
10. Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., Young, L. S.: Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 17, 339 (1993).
11. Chiang, A. K., Tao, Q., Srivastava, G., Ho, F. C.: Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68, 285 (1996).
12. Doyle, M. G., Catovsky, D., Crawford, D. H.: Infection of leukaemic B lymphocytes by Epstein-Barr virus. Leukemia 7, 1858 (1993).
13. Teramoto, N., Gogolak, P., Nagy, N., Maeda, A., Kvarnung, K., Bjorkholm, M., Klein, E.: Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle. J Hum Virol 3, 125 (2000).
14. Caligaris-Cappio, F., Hamblin, T. J.: B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17, 399 (1999).
15. Kurth, J., Hansmann, M. L., Rajewsky, K., Kuppers, R.: Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci U S A 100, 4730 (2003).
16. Oudejans, J. J., Jiwa, M., van den Brule, A. J., Grasser, F. A., Horstman, A., Vos, W., Kluin, P. M., van der Valk, P., Walboomers, J. M., Meijer, C. J.: Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 147, 923 (1995).
17. Maeda, A., Bandobashi, K., Nagy, N., Teramoto, N., Gogolak, P., Pokrovskaja, K., Szekely, L., Bjorkholm, M., Klein, G., Klein, E.: Epstein-Barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. J Hum Virol 4, 227 (2001).
18. Bandobashi, K., Liu, A., Nagy, N., Kis, L. L., Nishikawa, J., Bjorkholm, M., Klein, G., Klein, E.: EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells. Virus Genes 30, 323 (2005).
19. Babcock, G. J., Decker, L. L., Volk, M., Thorley-Lawson, D. A.: EBV persistence in memory B cells in vivo. Immunity 9, 395 (1998).
20. Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A.: Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A 102, 18093-18098 (2005).
21. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., Rickinson, A. B.: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6, 2743 (1987).
22. Contreras-Brodin, B. A., Anvret, M., Imreh, S., Altiok, E., Klein, G., Masucci, M. G.: B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. J Gen Virol 72, 3025 (1991).
23. Araujo, I., Foss, H. D., Hummel, M., Anagnostopoulos, I., Barbosa, H. S., Bittencourt, A., Stein, H.: Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol 187, 326 (1999).
24. Babcock, G. J., Hochberg, D., Thorley-Lawson, D. A.: The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497 (2000).
25. Kis, L. L., Takahara, M., Nagy, N., Klein, G., Klein, E.: Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Immunol Lett 104, 83 (2006).
26. Davenport, M. G., Pagano, J. S.: Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol 73, 3154 (1999).
27. Kis, L. L., Nishikawa, J., Takahara, M., Nagy, N., Matskova, L., Takada, K., Elmberger, P. G., Ohlsson, A., Klein, G., Klein, E.: The in vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1; CD40-ligand and IL-4 induces LMP-1 but not EBNA-2. Int J Cancer 113, 937 (2005).
28. Kis, L. L., Takahara, M., Nagy, N., Klein, G., Klein, E.: IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Blood 107, 2928 (2006).
29. Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J. S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H., Melbye, M.: Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349, 1324 (2003).
30. Kuppers, R.: Molecular biology of Hodgkin's lymphoma. Adv Cancer Res 84, 277 (2002).
31. Kanzler, H., Kuppers, R., Hansmann, M. L., Rajewsky, K.: Hodgkin and Reed Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184, 1495 (1996).
32. Lewin, N., Avila-Carino, J., Minarovits, J., Lennette, E., Brautbar, C., Mellstedt, H., Klein, G., Klein, E.: Detection of two Epstein-Barr-virus (EBV)-carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). Int J Cancer 61, 159 (1995).
33. Tomita, Y., Avila-Carino, J., Yamamoto, K., Mellstedt, H., Klein, E.: Recognition of B-CLL cells experimentally infected with EBV by autologous T lymphocytes. Immunol Lett 60, 73 (1998).
34. Roschke, V., Kopantzev, E., Dertzbaugh, M., Rudikoff, S.: Chromosomal translocations deregulating c-myc are associated with normal immune responses. Oncogene 14, 3011 (1997).
35. Takada, K.: Role of Epstein-Barr virus in Burkitt's lymphoma. Curr Top Microbiol Immunol 258, 141 (2001).
36. Kennedy, G., Komano, J., Sugden, B.: Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc Natl Acad Sci U S A 100, 14269 (2003).
37. Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., Hansmann, M. L.: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91, 10962 (1994).
38. Schwering, I., Brauninger, A., Klein, U., Jungnickel, B., Tinguely, M., Diehl, V., Hansmann, M. L., Dalla-Favera, R., Rajewsky, K., Kuppers, R.: Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101, 1505 (2003).
39. Hertel, C. B., Zhou, X. G., Hamilton-Dutoit, S. J., Junker, S.: Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene 21, 4908 (2002).
40. Loddenkemper, C., Anagnostopoulos, I., Hummel, M., Johrens-Leder, K., Foss, H. D., Jundt, F., Wirth, T., Dorken, B., Stein, H.: Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol 202, 60 (2004).
41. Staratschek-Jox, A., Wolf, J., Diehl, V.: Hodgkin's disease. In: Masters, J. R. W., Palsson, B., editors. Human cell culture. Vol 3. Lymphoma and leukemia cell lines. Dordrecht: Kluwer Academic Press, 2000, pp. 339-353.
42. Vockerodt, M., Belge, G., Kube, D., Irsch, J., Siebert, R., Tesch, H., Diehl, V., Wolf, J., Bullerdiek, J., Staratschek-Jox, A.: An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. Br J Haematol 119, 640 (2002).
43. Carbone, A., Gloghini, A., Gruss, H. J., Pinto, A.: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147, 912 (1995).
44. Skinnider, B. F., Mak, T. W.: The role of cytokines in classical Hodgkin lymphoma. Blood 99, 4283 (2002).
45. Masucci, M. G., Contreras-Salazar, B., Ragnar, E., Falk, K., Minarovits, J., Ernberg, I., Klein, G.: 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael. J Virol 63, 3135 (1989).
46. Contreras-Brodin, B., Karlsson, A., Nilsson, T., Rymo, L., Klein, G.: B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. J Gen Virol 77, 1159 (1996).
47. Tierney, R., Kirby, H., Nagra, J., Rickinson, A., Bell, A.: The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/ Pax5. J Virol 74, 10458 (2000).
48. Anastasiadou, E., Boccellato, F., Cirone, M., Kis, L. L., Klein, E., Frati, L., Faggioni, A., Trivedi, P.: Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus. Leukemia 19, 1854 (2005).
49. Arguello, M., Sgarbanti, M., Hernandez, E., Mamane, Y., Sharma, S., Servant, M., Lin, R., Hiscott, J.: Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22, 964 (2003).
50. Kanzler, H., Kuppers, R., Hansmann, M. L., Rajewsky, K.: Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumour clone derived from (crippled) germinal center B cells. J Exp Med 184, 1495 (1996).
51. Mancao, C., Altmann, M., Jungnickel, B., Hammerschmidt, W.: Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106, 4339 (2005).
52. Bechtel, D., Kurth, J., Unkel, C., Kuppers, R.: Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood 106, 4345 (2005).
53. Chaganti, S., Bell, AI., Pastor, N. B., Milner, A. E., Drayson, M., Gordon, J., Rickinson, A. B.: Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. Blood 106, 4249 (2005).
54. Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., Dorken, B.: Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100, 296 (1997).
55. Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., Hay, R. T.: Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18, 3063 (1999).
56. Martin-Subero, J. I., Gesk, S., Harder, L., Sonoki, T., Tucker, P. W., Schlegelberger, B., Grote, W., Novo, F. J., Calasanz, M. J., Hansmann, M. L., Dyer, M. J., Siebert, R.: Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99, 1474 (2002).
57. Horie, R., Watanabe, T., Morishita, Y., Ito, K., Ishida, T., Kanegae, Y., Saito, I., Higashihara, M., Mori, S., Kadin, M. E., Watanabe, T.: Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene 21, 2493 (2002).
58. Babcock, G. J., Thorley-Lawson, D. A.: Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci U S A 97, 12250 (2000).
59. Frisan, T., Sjoberg, J., Dolcetti, R., Boiocchi, M., De Re, V., Carbone, A., Brautbar, C., Battat, S., Biberfeld, P., Eckman, M., Ost, A., Christenson, B., Sundstrom, C., Bjorkholm, M., Pisa, P., Masucci, M. G.: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86, 1493 (1995).
60. Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., Osato, T.: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335, 128 (1990).
61. Takahara, M., Kis, L. L., Nagy, N., Liu, A., Harabuchi, Y., Klein, G., Klein, E.: Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 and INF-gamma in the EBV-positive NK lines SNK6 and KAI3. Int J Canc (2006). In Press.